We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more,点击这里。通过继续使用我们的网站，您可以接受我们对cookie的使用。
Fujirebio是IVD测试领域的全球领导者，拥有50多年的构想，开发，生产和全球范围内的IVD产品商业化经验。These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variet。。。
DIAPEXQ流感A/B＆SARS-COV-2is a Real-time RT-PCR test for the qualitative detection of HA gene from Influenza A/B virus and N and ORF1a gene from SARS-CoV-2 in nasopharyngeal swab.
lumipulse g b•r•a•h•m•s pctimmunoreaction cartridges are for in vitro diagnostic (IVD) use with a two-step sandwich immunoassay method on the LUMIPULSE G system for the quantitative determination of procalcitonin (PCT) in human serum and plasma. The CE marked test is the most sensitive fully automated PCT test and the assay utilizes proven CLEIA (chemiluminescent enzyme immunoassay) technology with results that in up to 35 minutes.
iAMP COVID-19 SANO Assay is a real-time fluorescent RT-isothermal assay based on Atila’s proprietary isothermal amplification technology. The CE marked assay is intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs and saliva specimens from individuals with signs and symptoms of infection who are suspected of COVID-19.
The CE marked Lumipulse G SARS-CoV-2 Ag is designed for in vitro diagnostic (IVD) use with the Lumipulse G system for the detection and quantitative measurement of SARS-CoV-2 antigen in human nasopharyngeal swab or saliva. The assay is meant to be used as a diagnostic tool for the confirmation of a SARS-CoV-2 infection and utilizes proven CLEIA (chemiluminescent enzyme immunoassay) technology with results available in up to 35 minutes.
The CE marked Lumipulse® SARS-CoV-2 Ag Controls are intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analysis of SARS-CoV-2 antigen on the LUMIPULSE G System.
The CE marked Lumipulse® BNP Control are intended for use as an assayed quality control to monitor the precision of laboratory testing procedures for the analysis of human B-type natriuretic peptide (BNP) on the LUMIPULSE G Systems.
The CE marked Lumipulse® G AMH (anti-Müllerian hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the fully automated quantitative measurement of AMH in specimens based a two-step immunoassay method on the LUMIPULSE G System. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
The CE marked iAMP COVID-19 Detection Kit is designed for the qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment. Using isothermal amplification with real time fluorescence detection, the kit requires limited hands-on time and delivers fast sample-to-result within 75 to 90 minutes only.
